Most but not all prospective studies have reported a positive association between IGF-1 and breast cancer risk particularly in ER positive breast cancer however the influence of age and menopausal status remains ambivalent as highlighted in results of studies summarised in Table 1 (risk highlighted in bold) (Rinaldi et al., 2006
Survodutide side effects (Phase 2 data) Nausea: 56% of participants Vomiting: 27% Diarrhea: 22% Constipation: 21% Discontinuation due to adverse events: 24.6% Serious adverse events: 4.2% In the MASH trial, rates were even higher: nausea 66%, diarrhea 49%, vomiting 41%
Large rural population underserved for specialty caretelehealth shines here
It effectively targets and reduces the appearance of dark spots, pigmentation, and blemishes, revealing a complexion that exudes clarity and luminosity
We say class action, but it is not a pure class action